Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.
Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.
Atkins
Michael B
MB
Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. matkins@bidmc.harvard.edu
Ernstoff
Marc S
MS
Figlin
Robert A
RA
Flaherty
Keith T
KT
George
Daniel J
DJ
Kaelin
William G
WG
Kwon
Eugene D
ED
Libermann
Towia A
TA
Linehan
W Marston
WM
McDermott
David F
DF
Ochoa
Augusto C
AC
Pantuck
Allan J
AJ
Rini
Brian I
BI
Rosen
Mark A
MA
Sosman
Jeffrey A
JA
Sukhatme
Vikas P
VP
Vieweg
Johannes W
JW
Wood
Christopher G
CG
King
Laura
L
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009362:Neoplasm Metastasis; D011379:Prognosis
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents